Ovation iX Iliac Stent Graft Iliac Limb (REF TV-IL1412100-J)Recalls & reported problems
Endologix LLC · The TriVascular® Ovation Prime® Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft is an endovascular device delivered via a small diameter catheter to treat abdominal aortic aneurysms (AAAs). The stent graft is designed to reline the diseased vasculature, providing an endovascular blood conduit for isolating the aneurysm from the high pressure flow of blood, thereby reducing the risk of rupture. The stent graft is a modular configuration comprised of an aortic body section, iliac limbs, and iliac extensions as required. The TriVascular Ovation Prime Abdominal Stent Graft System with the Ovation iX Iliac Stent Graft includes, an Aortic Body Stent Graft and delivery catheter, Iliac Limb Stent Grafts and delivery catheters, Iliac Extension Stent Grafts and delivery catheters, as required, a Fill Polymer Kit, and an Autoinjector. · Class 3 · Implant
All models of Ovation iX Iliac Stent Graft (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI M701TVIL1412100J1), received between Feb 27, 2018 and Aug 28, 2025 — classified as 4 injuries.
The most frequently reported specific device problem is “Complete Blockage” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Complete Blockage1
- Device Stenosis1
- Device-Device Incompatibility1
- Difficult to Advance1
- Insufficient Device Problem Information1
Patient problems
- Failure of Implant2
- Hematoma1
- No Consequences Or Impact To Patient1
- Obstruction/Occlusion1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryAug 28, 2025Device Stenosis; Device Stenosis
THE PATIENT WAS IMPLANTED WITH THE OVATION IX ABDOMINAL STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA) ON (B)(6) 2018. ON (B)(6) 2019 THE PATIENT DEVELOPED AN OCCLUDED RIGHT LIMB WITH THROMBUS IN THE RIGHT COMMON FEMORAL ARTERY ANEURYSM. THE PHYSICIAN ELECTED TO PERFORM A THROMBECTOMY OF THE RIGHT INTERNAL ILIAC ARTERY AS WELL AS IMPLANT UNKNOWN (NON-ENDOLOGIX) BILATERAL COMMON ILIAC ARTERY STENTS. THEN A RIGHT EXTERNAL ILIAC ARTERY/SUPERFICIAL FEMORAL ARTERY EMBOLECTOMY WAS PERFORMED, AN OPEN THROMBECTOMY OF THE RIGHT CORONARY FEMORAL ARTERY WAS PERFORMED, AND A VIABAHN (NON-ENDOLOGIX) STENT WAS PLACED FROM THE RIGHT SUPERFICIAL FEMORAL ARTERY TO BELOW-KNEE POPLITEAL ARTERY. THE FINAL PATIENT'S STATUS WAS REPORTED AS STABLE.
Patient problems: Obstruction/Occlusion
MAUDE report 22913272 ↗InjuryOct 10, 2022Insufficient Device Problem Information; Insufficient Device Problem Information
THE PATIENT WAS INITIALLY IMPLANTED WITH AN OVATION IX STENT GRAFT SYSTEM TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). IT WAS REPORTED THAT DURING THE INITIAL PROCEDURE THE GRAFT WAS DIFFICULT TO DEMATE, THE IMPLANT WAS DISPLACED AND THERE WAS TYPE 1A ENDOLEAK. THIS EVENT WAS PREVIOUSLY CAPTURED PER PATIENT ID (B)(6). PATIENT WAS NOT IN ROUTINE FOLLOW-UP CARE. APPROXIMATELY SIX (6) YEARS POST IMPLANT THE PHYSICIAN REPORTED THAT THE AAA RUPTURED FROM A TYPE 1 ENDOLEAK. UPON FURTHER REVIEW IT APPEARS THERE WAS A JUXTARENAL ANEURYSM THAT MAY HAVE CAUSED THE RUPTURE AS THERE WAS NO VISIBLE TYPE 1A ENDOLEAK, AND THE ISSUE APPEARS TO BE WHERE THAT PROXIMAL CROWN IS ABOVE THE OVATION IX FABRIC. THE PHYSICIAN ELECTED TO IMPLANT A COOK PMEG (PHYSICIAN MODIFIED ENDOGRAFT) (NON-ENDOLOGIX) STENT TO RESOLVE THIS EVENT. THE PATIENT WAS REPORTED AS DOING WELL POST THIS SECONDARY PROCEDURE ON (B)(6) 2022. THIS EVENT WAS PREVIOUSLY CAPTURED PER PATIENT ID (B)(6). ADDITIONALLY, DURING THE INITIAL IMPLANT PROCEDURE, A LACERATION OCCURRED THAT REQUIRED EMERGENT REPAIR. IN ADDITION, PATIENT RETURNED TO THE HOSPITAL TWELVE (12) DAYS POST INITIAL PROCEDURE FOR BLOOD TRANSFUSION AND LEFT GROIN HEMATOMA EV
Patient problems: Failure of Implant; Hematoma
MAUDE report 15570932 ↗InjurySep 20, 2021Complete Blockage; Device-Device Incompatibility; Complete Blockage; Device-Device Incompatibility
THE PATIENT WAS INITIALLY IMPLANTED WITH AN AFX2 BIFURCATED STENT GRAFT, A VELA SUPRARENAL EXTENSION AND AN OVATION LIMB EXTENSION TO TREAT AN ABDOMINAL AORTIC ANEURYSM (AAA). THIS CASE IS OUTSIDE THE INDICATIONS OF USE (OFF -LABEL) DUE THE USE OF AFX WITH OVATION DEVICES. APPROXIMATELY ONE (1) DAY POST INITIAL PROCEDURE, THE PATIENT PRESENTED WITH THROMBOSIS OF THE RIGHT LIMB CAUSING AN OCCLUSION OF THE STENT GRAFT. THE PHYSICIAN SUCCESSFULLY TREATED THE PATIENT BY IMPLANTING TWO (2) BARE METAL PERIPHERAL STENTS (NON-ENDOLOGIX) AND THE PATIENT IS REPORTEDLY DOING WELL.
Patient problems: Failure of Implant
MAUDE report 12502486 ↗InjuryFeb 27, 2018Difficult to Advance; Difficult to Advance
AN OVATION IX ILIAC LIMB STENT GRAFT SYSTEM WAS IMPLANTED TO TREAT AN ABDOMINAL AORTIC ANEURYSM. DURING THE PROCEDURE, THE IPSILATERAL LIMB WAS UNABLE TO BE ADVANCED, DESPITE TROUBLESHOOTING TECHNIQUES. PHYSICIAN ELECTED TO REMOVE THE DEVICE AND USE A NEW DEVICE. THE LIMB WAS SUCCESSFULLY IMPLANTED AND THE CASE CONCLUDED WITH SUCCESSFUL ANEURYSM EXCLUSION. THERE WAS NO PATIENT SEQUELAE AS RESULT OF THIS EVENT, AND AS OF THE DATE OF THIS REPORT THERE HAVE BEEN NO ADDITIONAL PATIENT SEQUELAE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7299390 ↗
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page